9,978,100,000 Shares of Common Stock Offered by Selling Stockholders
This prospectus relates to the resale, from time to time, by the selling stockholders listed in this prospectus under the section “Selling Stockholders,” of up to 9,978,100,000 shares of common stock, par value $.0001 per share, of Rennova Health, Inc., issuable upon the exercise of Series B Warrants which we sold to the Selling Stockholders in private placements on March 21, 2017.
Our common stock is traded on the OTC Pink under the symbol “RNVA.” The last reported sales price of our common stock on May 10, 2023 was $0.0001 per share. There were 29,934,322,257 shares of our common stock outstanding as of May 1, 2023.
This prospectus relates to the resale, from time to time, by the selling stockholders listed in this prospectus under the section “Selling Stockholders,” of up to 9,978,100,000 shares of common stock, par value $.0001 per share, of Rennova Health, Inc., issuable upon the exercise of Series B Warrants which we sold to the Selling Stockholders in private placements on March 21, 2017.
Our common stock is traded on the OTC Pink under the symbol “RNVA.” The last reported sales price of our common stock on May 10, 2023 was $0.0001 per share. There were 29,934,322,257 shares of our common stock outstanding as of May 1, 2023.
